Literature DB >> 35643941

Delayed platelet recovery and mortality after allogeneic stem cell transplantation in children.

Joseph R Wells1, Guolian Kang2, Ali Y Suliman3, Ying Li3, Salem Akel4, Brandon Triplett3,5, Ashok Srinivasan6,7.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35643941      PMCID： PMC9429998          DOI： 10.1038/s41409-022-01726-2

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.174


× No keyword cloud information.
  10 in total

1.  Delayed platelet recovery after allogeneic transplantation: a predictor of increased treatment-related mortality and poorer survival.

Authors:  P Ramírez; C G Brunstein; B Miller; T Defor; D Weisdorf
Journal:  Bone Marrow Transplant       Date:  2010-10-04       Impact factor: 5.483

2.  Effect of Total Nucleated and CD34(+) Cell Dose on Outcome after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Mats Remberger; Johan Törlén; Olle Ringdén; Mats Engström; Emma Watz; Michael Uhlin; Jonas Mattsson
Journal:  Biol Blood Marrow Transplant       Date:  2015-02-04       Impact factor: 5.742

3.  Relevance of bone marrow cell dose on allogeneic transplantation outcomes for patients with acute myeloid leukemia in first complete remission: results of a European survey.

Authors:  Vanderson Rocha; Myriam Labopin; Eliane Gluckman; Ray Powles; William Arcese; Andrea Bacigalupo; Josy Reiffers; Arturo Iriondo; Olle Ringdén; Tapani Ruutu; Francesco Frassoni
Journal:  J Clin Oncol       Date:  2002-11-01       Impact factor: 44.544

4.  Prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation: associations with impaired platelet production and increased platelet turnover.

Authors:  R Yamazaki; M Kuwana; T Mori; Y Okazaki; Y Kawakami; Y Ikeda; S Okamoto
Journal:  Bone Marrow Transplant       Date:  2006-09       Impact factor: 5.483

5.  CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies.

Authors:  D Mavroudis; E Read; M Cottler-Fox; D Couriel; J Molldrem; C Carter; M Yu; C Dunbar; J Barrett
Journal:  Blood       Date:  1996-10-15       Impact factor: 22.113

6.  Delayed platelet recovery after allogeneic hematopoietic stem cell transplantation: Association with chronic graft-versus-host disease and survival outcome.

Authors:  Yu Akahoshi; Shun-Ichi Kimura; Ayumi Gomyo; Jin Hayakawa; Masaharu Tamaki; Naonori Harada; Machiko Kusuda; Kazuaki Kameda; Tomotaka Ugai; Hidenori Wada; Yuko Ishihara; Koji Kawamura; Kana Sakamoto; Miki Sato; Kiriko Terasako-Saito; Misato Kikuchi; Hideki Nakasone; Shinichi Kako; Yoshinobu Kanda
Journal:  Hematol Oncol       Date:  2017-05-05       Impact factor: 5.271

7.  Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation.

Authors:  Henrique Bittencourt; Vanderson Rocha; Sylvie Chevret; Gérard Socié; Hélène Espérou; Agnès Devergie; Liliane Dal Cortivo; Jean-Pierre Marolleau; Federico Garnier; Patricia Ribaud; Eliane Gluckman
Journal:  Blood       Date:  2002-04-15       Impact factor: 22.113

8.  Decreased treatment failure in recipients of HLA-identical bone marrow or peripheral blood stem cell transplants with high CD34 cell doses.

Authors:  Olle Ringdén; A John Barrett; Mei-Jie Zhang; Fausto R Loberiza; Brian J Bolwell; Mitchell S Cairo; Robert Peter Gale; Gregory A Hale; Mark R Litzow; Rodrigo Martino; James A Russell; Pierre Tiberghien; Alvaro Urbano-Ispizua; Mary M Horowitz
Journal:  Br J Haematol       Date:  2003-06       Impact factor: 6.998

9.  No impact of total or myeloid Cd34+ cell numbers on neutrophil engraftment and transplantation-related mortality after allogeneic pediatric bone marrow transplantation.

Authors:  Herbert Pichler; Volker Witt; Elisabeth Winter; Heidrun Boztug; Evgenia Glogova; Ulrike Pötschger; Susanne Matthes-Martin; Gerhard Fritsch
Journal:  Biol Blood Marrow Transplant       Date:  2014-01-31       Impact factor: 5.742

10.  Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: influence of dose and stem cell source shows better outcome with rich marrow.

Authors:  Norbert C Gorin; Myriam Labopin; Vanderson Rocha; William Arcese; Meral Beksac; Eliane Gluckman; Olle Ringden; Tapani Ruutu; Josy Reiffers; Giuseppe Bandini; Michele Falda; Panagiotis Zikos; Roelf Willemze; Francesco Frassoni
Journal:  Blood       Date:  2003-06-26       Impact factor: 22.113
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.